| Description | MK 0893 is a potent, selective antagonist of glucagon receptor. |
| In vitro | MK 0893 is active against the rhesus monkey GCGR(IC50 of 56 nM in a cAMP assay with CHO cells expressing the rhesus GCGR)[1]. |
| In vivo | In hGCGR mice on a high fat diet, MK 0893 at 3, and 10 mpk po in feed lowers blood glucose levels by 89% and 94% at day 10, respectively, relative to the difference between the vehicle control and lean hGCGR mice[1]. |
| Target activity | Glucagon receptor:6.6 nM |
| molecular weight | 588.48 |
| Molecular formula | C32H27Cl2N3O4 |
| CAS | 870823-12-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 33.33 mg/mL (56.64 mM) |
| References | 1. Xiong Y, et al. Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the treatment of type II diabetes.J Med Chem. 2012 Jul 12; |